Cargando…

Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study

BACKGROUND: HIV transmission can occur with a viral load of at least 200 copies per mL of blood and low-level viraemia can lead to virological failure; the threshold level at which risk for virological failure is conferred is uncertain. To better understand low-level viraemia prevalence and outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chun, Helen M, Abutu, Andrew, Milligan, Kyle, Ehoche, Akipu, Shiraishi, Ray W, Odafe, Solomon, Dalhatu, Ibrahim, Onotu, Dennis, Okoye, McPaul, Oladipo, Ademola, Gwamna, Jerry, Ikpeazu, Akudo, Akpan, Nseobong M, Ibrahim, Jahun, Aliyu, Gambo, Akanmu, Sulaiman, Boyd, Mary A, Swaminathan, Mahesh, Ellerbrock, Tedd, Stafford, Kristen A, Dirlikov, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711923/ https://www.ncbi.nlm.nih.gov/pubmed/36400087 http://dx.doi.org/10.1016/S2214-109X(22)00413-2

Ejemplares similares

Effect of Test and Treat on clinical outcomes in Nigeria: A national retrospective study
por: Lavoie, Marie-Claude C., et al.
Publicado: (2023)

Health Workers’ Perspectives on the Outcomes, Enablers, and Barriers to the Implementation of HIV “Test and Treat” Guidelines in Abuja, Nigeria
por: Odafe, Solomon, et al.
Publicado: (2019)

Evaluation of the clinical outcomes of the Test and Treat strategy to implement Treat All in Nigeria: Results from the Nigeria Multi-Center ART Study
por: Stafford, Kristen A., et al.
Publicado: (2019)

Ensuring Optimal Community HIV Testing Services in Nigeria Using an Enhanced Community Case-Finding Package (ECCP), October 2019–March 2020: Acceleration to HIV Epidemic Control
por: Jahun, Ibrahim, et al.
Publicado: (2021)

Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 2020
por: Boyd, Andrew T., et al.
Publicado: (2021)

Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge
por: Jahun, Ibrahim, et al.
Publicado: (2021)

From Paper Files to Web-Based Application for Data-Driven Monitoring of HIV Programs: Nigeria's Journey to a National Data Repository for Decision-Making and Patient Care
por: Dalhatu, Ibrahim, et al.
Publicado: (2023)

Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018)
por: Jahun, Ibrahim, et al.
Publicado: (2022)

High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004–2012
por: Agolory, Simon G., et al.
Publicado: (2017)

Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012
por: Pathmanathan, Ishani, et al.
Publicado: (2017)

Mapping HIV prevalence in Nigeria using small area estimates to develop a targeted HIV intervention strategy
por: O’BRIEN-CARELLI, Caitlin, et al.
Publicado: (2022)

Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012
por: Dalhatu, Ibrahim, et al.
Publicado: (2016)

Correction: Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012
por: Dalhatu, Ibrahim, et al.
Publicado: (2017)

Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic — Nine States, Nigeria, March 31, 2019–September 30, 2020
por: Dirlikov, Emilio, et al.
Publicado: (2021)

Evaluation of the Nigeria national HIV rapid testing algorithm
por: Iriemenam, Nnaemeka C., et al.
Publicado: (2022)

The Burden of HIV, Hepatitis B and Hepatitis C by Armed Conflict Setting: The Nigeria AIDS Indicator and Impact Survey, 2018
por: Aliyu, Gambo G., et al.
Publicado: (2021)

Performance of HIV rapid testing algorithm in Nigeria: Findings from a household-based Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS)
por: Patel, Hetal K., et al.
Publicado: (2022)

Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants
por: Garcia-Knight, Miguel A., et al.
Publicado: (2017)

Control of HIV viraemia is not enough in perinatal HIV
por: Foster, Caroline, et al.
Publicado: (2015)

Increasing pediatric HIV testing positivity rates through focused testing in high-yield points of service in health facilities—Nigeria, 2016-2017
por: Odafe, Solomon, et al.
Publicado: (2020)

JC viraemia in kidney transplant recipients: to act or not to act?
por: Rao, N., et al.
Publicado: (2012)

Steroid harms if given early in COVID-19 viraemia
por: Arora, Kanupriya, et al.
Publicado: (2021)

Pleural effusion disease in rabbits: Observations on viraemia, immunity and transmissibility
por: Fennestad, K. L., et al.
Publicado: (1981)

Low-level viraemia despite emergence of dolutegravir-resistant variants
por: Botha, Johannes C., et al.
Publicado: (2022)

HIV-2 gene product-specific T cell responses and viraemia control
por: Leligdowicz, Aleksandra, et al.
Publicado: (2006)

Low level viraemia and the risk of virological failure in HIV infected patients
por: Florea, Dragoş, et al.
Publicado: (2014)

BTV-14 Infection in Sheep Elicits Viraemia with Mild Clinical Symptoms
por: Flannery, John, et al.
Publicado: (2020)

Evaluation on the antiviral activity of arctigenin against spring viraemia of carp virus
por: Shen, Yu-Feng, et al.
Publicado: (2018)

HIV: how to manage low-level viraemia in people living with HIV
por: Hanners, Emily K, et al.
Publicado: (2022)

Dominance of variant A in Human Herpesvirus 6 viraemia after renal transplantation
por: Csoma, Eszter, et al.
Publicado: (2011)

Hydroxycoumarin efficiently inhibits spring viraemia of carp virus infection in vitro and in vivo
por: Liu, Lei, et al.
Publicado: (2020)

Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa
por: Myer, Landon, et al.
Publicado: (2015)

Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia
por: Saison, Julien, et al.
Publicado: (2014)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
por: Nightingale, Sam, et al.
Publicado: (2016)

NS1 Antigenemia and Viraemia Load: Potential Markers of Progression to Dengue Fatal Outcome?
por: Nunes, Priscila Conrado Guerra, et al.
Publicado: (2018)

Human herpesvirus-6 viraemia in children with primary immunodeficiency undergoing stem-cell-transplantation
por: Taha, Y., et al.
Publicado: (2006)

Mobility during the post-partum period and viraemia in women living with HIV in South Africa
por: Odayar, Jasantha, et al.
Publicado: (2023)

Sustainability of Funding for HIV Treatment Services: A Cross-Sectional Survey of Patients' Willingness to Pay for Treatment Services in Nigeria
por: Durosinmi-Etti, Olawale, et al.
Publicado: (2022)

A Novel Case of Symptomatic BK Viraemia in a Patient Undergoing Treatment for Hodgkin Lymphoma
por: Perram, Jacinta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5o2nfqo7sm3v2ekl9k4b3phcnq